New Approaches to the Treatment of Pemphigus-Reference-Cited by-同舟云学术

New Approaches to the Treatment of Pemphigus

Published:2004-01 Issue:1 Volume:9 Page:84-91
ISSN:1087-0024
Container-title:Journal of Investigative Dermatology Symposium Proceedings
language:en
Short-container-title:Journal of Investigative Dermatology Symposium Proceedings

Author:

Grando Sergei A.

Publisher

Elsevier BV

Subject

Cell Biology,Dermatology,Molecular Biology,General Medicine,Biotechnology

Reference134 articles.

1. The nature of the interactions of pyridostigmine with the nicotinic acetylcholine receptor-ionic channel complex. II. Patch clamp studies;Akaike;Mol Pharmacol,1984

2. The interaction of anticholinesterase agents with the acetylcholine receptor-ionic channel complex;Albuquerque;Fund Appl Toxicol,1984

3. Autoantibodies against the amino-terminal cadherin-like binding domain of pemphigus vulgaris antigen are pathogenic;Amagai;J Clin Invest,1992

4. An inhibitory action of tetracyclines on guinea-pig myenteric plexus;Anadon;Arch Pharmacol,1987

5. A pathogenic autoantibody, pemphigus vulgaris-IgG, induces phosphorylation of desmoglein 3, and its dissociation from plakoglobin in cultured keratinocytes;Aoyama;Eur J Immunol,1999

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Updates on the Management of Autoimmune Bullous Diseases;Indian Dermatology Online Journal;2024-08-30

2. Cotrimoxazole as a Preventative Intervention for Pneumocystis Pneumonia in Pemphigus Patients Treated with Rituximab: A Retrospective Study;Dermatology and Therapy;2023-06-15

3. S2k guidelines on the management of paraneoplastic pemphigus/paraneoplastic autoimmune multiorgan syndrome initiated by the European Academy of Dermatology and Venereology (EADV);Journal of the European Academy of Dermatology and Venereology;2023-03-25

4. The Role of Non-Neuronal Acetylcholine in the Autoimmune Blistering Disease Pemphigus Vulgaris;Biology;2023-02-23

5. Effectiveness of topical pilocarpine in refractory oral lesions of pemphigus vulgaris: Results from an open‐label, prospective, pilot study;Dermatologic Therapy;2022-03-25